Literature DB >> 30905335

Oral Fosfomycin-Supplemental Information Necessary.

Klaus-Friedrich Bodmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30905335      PMCID： PMC6440377          DOI： 10.3238/arztebl.2019.0115a

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  2 in total

Review 1.  Treatment Options for Carbapenem- Resistant Gram-Negative Infections.

Authors:  Moritz Fritzenwanker; Can Imirzalioglu; Susanne Herold; Florian M Wagenlehner; Klaus-Peter Zimmer; Trinad Chakraborty
Journal:  Dtsch Arztebl Int       Date:  2018-05-21       Impact factor: 5.594

2.  Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database.

Authors:  Dmitri Iarikov; Ronald Wassel; John Farley; Sumathi Nambiar
Journal:  Infect Dis Ther       Date:  2015-10-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.